Data as of Nov 26
| +0.75 / +1.58%|
The 9 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 92.00, with a high estimate of 100.00 and a low estimate of 52.00. The median estimate represents a +90.87% increase from the last price of 48.20.
The current consensus among 9 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.